Original article

Mental health status of patients with esophageal symptoms and esophageal motility disorders during coronavirus pandemic

Expand
  • Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Online published: 2024-01-26

Abstract

Objective To investigate the mental health status of the patients with different esophageal symptoms and/or esophageal motility disorders during the coronavirus pandemic. Methods The data of 137 coronavirus-negative patients with different esophageal symptoms, who underwent high-resolution manometry(HRM) from April in 2020 to December in 2021 were retrospectively analyzed. The demographic characteristics, esophageal symptoms, HRM results, scores of 9-item patient health questionnaire (PHQ-9) and scores of 7-item generalized anxiety disorder (GAD-7) scale and the risk factors for psychological disorders were analyzed. Results In 137 patients who underwent HRM, 62.0%(85/137) cases had depression, and 59.9%(82/137) cases had anxiety. Most of the patients(97/137) with regurgitation presented anxiety (71.1%, P=0.045). However, the GAD-7 score in the patients with chest pain [18.00 (10.00-20.00)] was higher than that in the patients with other symptoms(P=0.049). The GAD-7 score[15.00(7.50-18.50)] in the patients without esophageal motility disorder was higher than that [9.00(6.00-13.00)] in the patients with esophageal motility disorder(P=0.012). A lower body mass index (BMI) was discovered in the moderate depression group(P=0.034) and in the severe anxiety group(P=0.008). There were more patients with regurgitation in severe anxiety group(P=0.035), while the mild anxiety group contained more patients with achalasia (P=0.009). Age<40 years[odds ratio (OR)=15.02, 95% confidence interval (CI): 2.50-90.30], BMI<18 kg/m2 (OR=9.37, 95%CI: 1.11-79.46), globus (OR=5.89, 95%CI: 1.09-31.75), regurgitation (OR=5.57, 95%CI: 1.12-27.64) and achalasia (OR=15.72, 95%CI: 2.82-87.71) were risk factors for anxiety, while single (OR=0.03, 95%CI: 0.00-0.61) was protective factors for anxiety. Conclusions Psychological disorders are common in the patients with esophageal symptoms and esophageal motility disorders during the coronavirus pandemic. Young age, low BMI, globus, regurgitation and achalasia are risk factors for anxiety, while single is protective factors of anxiety.

Cite this article

SONG Jiani, ZHU Ying, HUANG Jia, TANG Yuming, YAO Weiyan . Mental health status of patients with esophageal symptoms and esophageal motility disorders during coronavirus pandemic[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(05) : 309 -315 . DOI: 10.16138/j.1673-6087.2023.05.001

References

[1] Wilkinson JM, Halland M. Esophageal motility disorders[J]. Am Fam Physician, 2020, 102(5): 291-296.
[2] Carlson DA, Gyawali CP, Roman S, et al. Esophageal hypervigilance and visceral anxiety are contributors to symptom severity among patients evaluated with high-resolution esophageal manometry[J]. Am J Gastroenterol, 2020, 115(3): 367-375.
[3] Wang R, Wang J, Hu S. Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis[J]. BMC Gastroenterol, 2021, 21(1): 127.
[4] Durazzo M, Gargiulo G, Pellicano R. Non-cardiac chest pain: a 2018 update[J]. Minerva Cardioangiol, 2018, 66(6): 770-783.
[5] Clouse RE, Lustman PJ. Psychiatric illness and contraction abnormalities of the esophagus[J]. N Engl J Med, 1983, 309(22): 1337-1342.
[6] Hu Y, Chen Y, Zheng Y, et al. Factors related to mental health of inpatients with COVID-19 in Wuhan, China[J]. Brain Behav Immun, 2020, 587-593.
[7] Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0[J]. Neurogastroenterol Motil, 2015, 27(2): 160-174.
[8] Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure[J]. J Gen Intern Med, 2001, 16(9): 606-613.
[9] L?we B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population[J]. Med Care, 2008, 46(3): 266-274.
[10] Kim CH, Hsu JJ, Williams DE, et al. A prospective psychological evaluation of patients with dysphagia of various etiologies[J]. Dysphagia, 1996, 11(1): 34-40.
[11] Lee BE, Kim GH. Globus pharyngeus: a review of its etiology, diagnosis and treatment[J]. World J Gastroenterol, 2012, 18(20): 2462-2471.
[12] Patel D, Fass R, Vaezi M. Untangling nonerosive reflux disease from functional heartburn[J]. Clin Gastroenterol Hepatol, 2021, 19(7): 1314-1326.
[13] Losa M, Manz SM, Schindler V, et al. Increased visceral sensitivity, elevated anxiety, and depression levels in patients with functional esophageal disorders and non-erosive reflux disease[J]. Neurogastroenterol Motil, 2021, 33(9): e14177.
[14] Kessing BF, Bredenoord AJ, Saleh CM, et al. Effects of anxiety and depression in patients with gastroesophageal reflux disease[J]. Clin Gastroenterol Hepatol, 2015, 13(6):1089-1095.
[15] Webster R, Norman P, Goodacre S, et al. The prevalence and correlates of psychological outcomes in patients with acute non-cardiac chest pain: a systematic review[J]. Emerg Med J, 2012, 29(4): 267-273.
[16] Deng J, Zhou F, Hou W, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis[J]. Ann N Y Acad Sci, 2021, 1486(1):90-111.
[17] Santabárbara J, Lasheras I, Lipnicki DM, et al. Prevalence of anxiety in the COVID-19 pandemic: an updated meta-analysis of community-based studies[J]. Prog Neu-ropsychopharmacol Biol Psychiatry, 2021, 109: 110207.
[18] Sikavi DR, Cai JX, Carroll TL, et al. Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms[J]. J Gastroenterol Hepatol, 2021, 36(8): 2076-2082.
[19] Song CW, Lee SJ, Jeen YT, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility[J]. Am J Gastroenterol, 2001, 96(8): 2312-2316.
[20] Finkenbine R, Miele VJ. Globus hystericus: a brief review[J]. Gen Hosp Psychiatry, 2004, 26(1): 78-82.
[21] Zhang L, Zhang L, Zhao W, et al. Influence of anxiety and depression on the symptoms of achalasia patients[J]. Dig Dis, 2023, 41(3): 362-368.
[22] Herhaus B, Kersting A, Br?hler E, et al. Depression, anxiety and health status across different BMI classes[J]. J Affect Disord, 2020, 276: 45-52.
[23] Sahle BW, Breslin M, Sanderson K, et al. Association between depression, anxiety and weight change in young adults[J]. BMC Psychiatry, 2019, 19(1): 398.
[24] Zhu C, Zhang T, Li Q, et al. Depression and anxiety during the COVID-19 pandemic: epidemiology, mechanism, and treatment[J]. Neurosci Bull, 2023, 39(4): 675-684.
[25] Fu W, Wang C, Zou L, et al. Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan, China[J]. Transl Psychiatry, 2020, 10(1): 225.
Options
Outlines

/